Earnings per Share (Tables)

6 Months Ended

Jun. 30, 2023

Earnings Per Share [Abstract]

Basic and diluted earnings per share

Basic and diluted shares outstanding used in our earnings per share calculation are calculated as follows:

	For the Three Months Ended June 30,				For the Six Months Ended June 30,
(In millions)	2023		2022		2023		2022
Numerator:
Net income attributable to Biogen Inc.	$	591.6	$	1,058.0	$	979.5	$	1,361.8
Denominator:
Weighted average number of common shares outstanding	144.7		145.9		144.6		146.5
Effect of dilutive securities:
Time-vested restricted stock units	0.7		0.2		0.7		0.2
Performance stock units settled in stock	0.1		0.1		0.1		0.1
Dilutive potential common shares	0.8		0.3		0.8		0.3
Shares used in calculating diluted earnings per share	145.5		146.2		145.4		146.8